Global pharma giants double down on China, betting on long-term growth
This is the latest sign of global healthcare giants doubling down on the market in recent years. Experts noted on Monday that ...
China.org.cn1d
Economic Watch: Pharmaceutical multinationals double down on China's biotech innovations
BEIJING, March 27 (Xinhua) -- Multinational pharmaceutical firms, particularly U.S. giants, are increasingly recognizing China's burgeoning innovative drug sector as a strategic goldmine to bolster ...
China promotes business potential to Apple, Pfizer and other US companies
China sought to reassure foreign corporate chiefs of the country's business potential when Vice Premier He Lifeng met with ...
China touts business potential to US companies despite 'rising instability'
China sought to reassure foreign corporate chiefs of the country's business potential when Vice Premier He Lifeng met with ...
China reassures Apple, Pfizer, Cargill, others of business potential
U.S. Republican Senator Steve Daines, a staunch supporter of President Donald Trump, met Li on Sunday with seven senior ...
Forbes25d
LLY Stock: Should You Buy After A 20% Rise?
Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...
The Motley Fool26d
Where Will Eli Lilly Be in 5 Years?
Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.